Will a person who chewed 25 oxycodone tablets and ingested 45 mg of lorazepam lose consciousness rapidly?

Yes, Loss of Consciousness Will Occur Rapidly and This is a Life-Threatening Emergency

A person who has ingested 25 oxycodone tablets (chewed) combined with 45 mg of lorazepam will lose consciousness rapidly and is at extreme risk of respiratory arrest and death. This represents a massive combined opioid-benzodiazepine overdose requiring immediate emergency medical intervention.

Why Rapid Loss of Consciousness is Expected

Synergistic CNS Depression

Both oxycodone and lorazepam cause profound central nervous system depression through different mechanisms that potentiate each other 1:

• Opioid mechanism: Oxycodone causes CNS depression leading to respiratory compromise through loss of protective airway reflexes
• Benzodiazepine mechanism: Lorazepam acts as a GABA-A receptor agonist, producing sedation and respiratory depression
• Combined effect: The 2023 AHA guidelines explicitly warn that "taking oxycodone hydrochloride tablets with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants can cause severe drowsiness, decreased awareness, breathing problems, coma, and death" 2

Massive Doses Involved

The quantities described represent extreme overdoses:

• Oxycodone: 25 tablets chewed (assuming standard 5-10mg tablets = 125-250mg minimum, potentially much higher with extended-release formulations). Research documents that even 70mg immediate-release caused significant toxicity requiring naloxone 3, and this dose is 2-4 times higher
• Lorazepam: 45mg is approximately 22 times the typical maximum daily therapeutic dose. Lorazepam peaks at 2 hours with 90% bioavailability 4

Chewing Accelerates Absorption

Chewing oxycodone tablets, particularly extended-release formulations, defeats time-release mechanisms and causes immediate absorption of the entire dose, accelerating onset of toxicity 5.

Expected Timeline and Clinical Course

Onset: Loss of consciousness will likely begin within 15-30 minutes and progress rapidly:

• Lorazepam reaches peak plasma levels at approximately 2 hours but CNS effects begin much earlier 4
• Chewed oxycodone provides immediate absorption rather than controlled release
• The synergistic effect means consciousness will be lost well before either drug reaches peak levels individually

Duration: This will be a prolonged emergency lasting days, not hours:

• Lorazepam has a half-life of approximately 12 hours 4
• Sustained-release oxycodone overdoses required mechanical ventilation for 3 days in documented cases 5
• One case of massive oxycodone ingestion proved "refractory to naloxone therapy" and required 3 days of mechanical ventilation 5

Critical Life-Threatening Complications

Respiratory Arrest

The primary cause of death will be respiratory failure 1:

• Loss of protective airway reflexes
• Hypoventilation leading to hypoxemia and hypercarbia
• Aspiration risk from mucus and gastric contents
• Non-cardiogenic pulmonary edema documented in massive oxycodone overdoses 5

Cardiovascular Effects

• Bradycardia (documented in 18% of oxycodone overdoses, with 5 patients having HR <50 bpm) 3
• QT prolongation possible with oxycodone 3
• Hypotension from combined CNS depression

Fatal Drug Interaction

A documented fatal case involved oxycodone (0.60 µg/mL plasma) and clonazepam (1.41 µg/mL plasma) showing "pathologies consistent with severe CNS and respiratory depression...including collapsed lungs, aspirated mucus, and heart failure" 6. The doses described in your question are substantially higher.

Immediate Management Required

This person requires immediate 911 activation and emergency department care 1:

1. Airway management is priority: Establish open airway, provide bag-mask ventilation, prepare for endotracheal intubation 1

2. Naloxone administration: Despite the benzodiazepine co-ingestion, naloxone should be administered immediately for the opioid component 1. However, be prepared that naloxone may be only partially effective or require continuous infusion given the massive dose and benzodiazepine synergy 5, 3

3. Flumazenil considerations: The 2023 AHA guidelines note flumazenil can reverse benzodiazepine-induced CNS and respiratory depression 1, BUT it carries significant risks:

   • May precipitate refractory seizures in benzodiazepine-tolerant patients
   • May not fully reverse respiratory depression in mixed overdoses
   • Can cause dysrhythmias, particularly with hypoxia present
   • Recent safety data are lacking 1

4. Prolonged monitoring: Expect ICU admission with mechanical ventilation for multiple days 5, 3

Critical Pitfalls

• Do not delay naloxone because benzodiazepines are involved—treat the opioid component aggressively 1
• Do not assume naloxone will be sufficient—this mixed overdose may require mechanical ventilation regardless 5
• Do not underestimate duration—sustained-release formulations and the massive doses mean toxicity will persist for days, not hours 5, 3
• Contact Poison Control (1-800-222-1222 in US) for expert toxicology guidance 1

Bottom line: This is a medical emergency with high mortality risk. Loss of consciousness will occur rapidly (minutes to under an hour), and death from respiratory arrest is likely without immediate advanced life support.